Cargando…
Amorphous and Co-Amorphous Olanzapine Stability in Formulations Intended for Wet Granulation and Pelletization
The preparation of amorphous and co-amorphous systems (CAMs) effectively addresses the solubility and bioavailability issues of poorly water-soluble chemical entities. However, stress conditions imposed during common pharmaceutical processing (e.g., tableting) may cause the recrystallization of the...
Autores principales: | da Costa, Nuno F., Daniels, Rolf, Fernandes, Ana I., Pinto, João F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499418/ https://www.ncbi.nlm.nih.gov/pubmed/36142179 http://dx.doi.org/10.3390/ijms231810234 |
Ejemplares similares
-
In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of Pellets
por: da Costa, Nuno F., et al.
Publicado: (2022) -
Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder Blends
por: da Costa, Nuno F., et al.
Publicado: (2022) -
Assessment of the stability of co-amorphous olanzapine in tablets
por: da Costa, Nuno F., et al.
Publicado: (2021) -
Comparison of the amorphization ability of two polymorphic forms of olanzapine
por: Chendo, Catarina, et al.
Publicado: (2021) -
Characterisation and stability of co-amorphous systems containing olanzapine and sulphonic acids
por: Santos, Inês A., et al.
Publicado: (2021)